New study shows involvement of low vitamin K status in IBD
New observational study from Croatia published in World Journal of Gastroenterology shows involvement of low vitamin K status in IBD pathophysiology through inflammation process and disease activity. Study results support experimental data of MGP immunomodulatory IBD effect and indicate potential involvement in the pathophysiology of the disease, and possibly extraintestinal manifestations. Below we present an abstract and a link to the entire study.
Abstract: Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease
BACKGROUND
Matrix Gla protein (MGP) is a vitamin K dependent peptide which has an established role in suppression of vascular calcification. Recent studies have pointed to a possible link between immunomodulatory effect of MGP and inflammatory bowel disease (IBD).
AIM
To compare plasma levels of dephosphorylated and uncarboxylated MGP (dp-ucMGP) between IBD patients and controls.
METHODS
This cross-sectional study was conducted on 70 patients with IBD (30 patients with ulcerative colitis and 40 patients with Crohn’s disease) and 60 age and gender matching healthy controls. Plasma dp-ucMGP levels were analyzed from blood samples by CLIA method using IDS-iSYS InaKtif MGP (Immunodiagnostic Systems, Frankfurt, Germany) according to the manufacturer’s instructions. fecal calprotectin (FC) levels were determined from stool samples by turbidimetric immunoassay method using Bühlmann fecal calprotectin turbo assay (Bühlmann Laboratories Aktiengesellschaft, Schonenbuch, Switzerland). Other parameters were analyzed according to the standard laboratory procedures.
RESULTS
Plasma levels of dp-ucMGP were significantly higher in patients with IBD compared to the healthy control group (629.83 ± 124.20 pmol/mL vs 546.7 ± 122.09 pmol/mL, P < 0.001), and there was no significant difference between patients with Crohn’s disease and patients with ulcerative colitis (640.02 ± 131.88 pmol/mL vs 616.23 ± 113.92 pmol/mL, P = 0.432). Furthermore, a significant positive correlation of plasma dp-ucMGP levels was found with both FC levels (r = 0.396, P < 0.001) and high sensitivity C-reactive protein (hsCRP) levels (r = 0.477, P < 0.001). Moreover, in the total study population a significant positive correlation was found between dp-ucMGP with age (r = 0.210, P = 0.016) and waist circumference (r = 0.264, P = 0.002). Multiple linear regression analysis showed that dp-ucMGP levels retained significant association with FC (β ± SE, 0.06 ± 0.02, P = 0.003).
CONCLUSION
Study results support experimental data of MGP immunomodulatory IBD effect and indicate potential involvement in the pathophysiology of the disease, and possibly extraintestinal manifestations.


Recommended:

Vitamin K2 in children and adolescents – why is it worth supplementing it!

Low vitamin K status predictive of COVID-19 mortality

New studies: Vitamin K2 Holds Promise for Alzheimer’s Prevention and Treatment

Vitamin K2 Status and Health Concerns

Vitamin K2 needs RDI – new review paper

Preliminary research links low vitamin K status to worse outcomes for COVID-19 patients

Menaquinones and the association with coronary heart disease

A protective role of vitamin K in the cardiovascular system

The importance of optimal vitamin K status in kidney patients
Vitamin K2 Improves Arterial Stiffness in Renal Transplant Patients

The relationship between vitamin K and peripheral arterial disease

Collagen and green tea in relation to skin protection

Essential vitamins
Vitamin K2 and Bone Health
